2 completed, 2 recruiting, 1 unknown. 2 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Cholesterolemia: new trials by email Literature Review of Cholesterolemia trials Research Report on Cholesterolemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study To Evaluate The Efficacy And Safety Of A Nutritional Supplement Based On Bergamot, Artichoke And Other Ingredients For Reducing Cholesterol Levels In Patients With Hypercholesterolemia (Metachol+) ARKOSTEROL - Cholesterolemia | Not applicable | Recruiting | Laboratoires Arkopharma | 207 | 2025-04-20 | 2025-09-17 |
| Stand Up Kansas: An Intervention to Reduce Sedentary Behavior in the Home Work Environment Desk Only, Program Only - Sedentary Behavior, Behavior, Health | Not applicable | Unknown | Kansas State University | 100 | 2020-10-21 | 2020-11-24 |
| Metabolic and Bone Changes After Adjuvant Cancer Treatments in Early Non-metastatic Breast Cancer Bone Fracture, Glucose, High Blood | Recruiting | Copenhagen University Hospital, Rigshospitalet | 120 | 2018-12-17 | 2021-09-16 | |
| Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C Bempedoic acid + Ezetimibe FDC Oral Tablet, Ezetimibe 10 mg Oral Tablet, Placebo Oral Tablet - Diabetes, Diabetes Mellitus, Type 2 | Phase 2 | Completed | Esperion Therapeutics, Inc. | 242 | 2018-05-09 | 2020-04-09 |
| Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each Monotherapy DP-R208, Candesartan32mg, Rosuvastatin 20mg - Hypertension, Cholesterolemia | Phase 3 | Completed | Alvogen Korea | 219 | 2015-12-01 | 2016-12-26 |
Hypertension (3) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Fatigue (1) · Fractures, Bone (1) · Health Behavior (1) · Insulin Resistance (1) · Motor Activity (1) · Obesity (1) · Sedentary Behavior (1)
Cardiovascular Diseases (3) · Nutritional and Metabolic Diseases (3) · Vascular Diseases (3) · Glucose Metabolism Disorders (2) · Metabolic Diseases (2) · Behavior (1) · Body Weight (1) · Endocrine System Diseases (1) · Hyperinsulinism (1) · Nutrition Disorders (1) · Overnutrition (1) · Overweight (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Wounds and Injuries (1)
8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid (1) · Ezetimibe (1) · Rosuvastatin Calcium (1) · Tablets (1) · candesartan (1)
Alvogen Korea (1) · Copenhagen University Hospital, Rigshospitalet (1) · Esperion Therapeutics, Inc. (1) · Kansas State University (1) · Laboratoires Arkopharma (1)
United States (2) · Denmark (1) · South Korea (1) · Spain (1)
Changkyu Park (1) · Emily L Mailey, PhD (1) · Guyoux Aurelie (1) · Peter Schwarz, Prof, MD (1) · Ron Haberman, MD (1)
PMID 31307833, PMID 37439084, PMID 39108148, PMID 39415181, PMID 41172892